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Initially described in 1992 (1), thoracoscopic (VATS) 
lobectomy is unquestionably the greatest upheaval in thoracic 
surgery community since the introduction of one-lung 
ventilation by Carlens in 1949 (2).In the last twenty years, 
after several initial uncertainty about its adoption, VATS 
lobectomy slowly but constantly propagates worldwide 
and, nowadays, most international guidelines suggest the 
adoption of this minimally invasive approach for early-stage 
lung cancer, over the traditional “open” approaches (3,4). 
Indeed, several single- and multi-institutional studies, as well 
as national registry analysis, showed that VATS lobectomy 
adoption permits a shorter chest tube duration, a shorter 
length of hospital stay, fewer postoperative complications, 
and a lower or comparable perioperative mortality vs. 
classic thoracotomy (5-13). Moreover, the recent results 
of UK multicentric VIOLET randomized controlled trial 
corroborated these statements, demonstrating an association 
between VATS lobectomy and enhanced short-term clinical 
outcomes when compared with open surgery for non-small 
cell lung cancer (NSCLC) (14,15).
Nevertheless, even if VATS lobectomy adoption is 
constantly increasing, its diffusion was not as fast as 
anticipated. For instance, VATS lobectomy rates were 30% 
in Europe (16), 50% in Italy (17), 65% in Denmark (18), 
29% in Great Britain and Ireland (19), and 30–40% in 
the USA (20). This retard in VATS lobectomy adoption, 
was initially imputable to the skepticism concerning the 
reliability and the safety of the technique, compared to the 
well-established thoracotomy approaches. Currently, the 
major concerns are represented by short- and long-term 
oncologic results, that are closely correlated with long-term 
survival (21).
In this scenario, we read with great interest the recent 
article by Yang et al. presenting the results of the first 
national analysis assessing long-term outcomes of VATS 
versus open lobectomy in stage I NSCLC (22). Actually, 
the previous analysis of national registry couldn’t define 
long-term outcomes due to data unavailability (5-12). 
Moreover, as secondary endpoint, the authors present short 
term results, including oncological surrogates’ outcomes 
like pathologic nodal upstaging, lymph node retrieval and 
surgical margin positivity. 
The authors reported no significant differences for 5-year 
overall survival between the VATS and open lobectomy, 
in both multivariable-adjusted survival analysis (HR: 0.95; 
95% CI: 0.86–1.05) and propensity score-matched survival 
analysis (5-year survival: VATS 66.3% vs. Opens 65.8%). 
This result is consistent with the current literature, that, so 
far, was merely based on smaller mono-institutional reports. 
Moreover, the authors address another point of 
particular concern, as the quality of lymph node assessment. 
Undeniably, while all the current guidelines underline the 
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prominence of lymph node assessment, this procedure is not 
regularly performed as it should. In particular, American 
College of Surgeons and US Surveillance, Epidemiology, 
and End Results (SEER) reported that mediastinal lymph 
nodes are rarely investigated in the majority of surgical 
procedures (23,24). In this context, nodal upstaging is 
considered one of the indexes of the oncological quality 
of the resection. Unfortunately, the current literature is 
inconsistent regarding this topic: several studies showed 
no differences in nodal upstaging between VATS and open 
lobectomy (25,26), while other reported a reduced nodal 
upstaging in VATS lobectomy procedures (12,21,27). In 
the present article, the results indicated that there were no 
significant differences in nodal upstaging between VATS 
and open lobectomy procedures; and these findings were 
confirmed if considered the N0 to N1 and the N0 to 
N2 upstaging. These results suggested an equivalence in 
oncologic efficacy of VATS lobectomy as compared to open 
approaches, once overcome the initial learning curve. 
Certainly, stronger evidence on short-term outcomes will 
be soon provided by the VIOLET study that showed similar 
results reporting a comparable rate of nodal upstaging 
between VATS and open lobectomy groups (15). On the 
other hand, we believe that with the continuous spread 
of VATS lobectomy adoption, and the parallel enhance 
of surgeon expertise with the technique, most of the 
future evidences will converge in defining the oncological 
equivalence of VATS and open lobectomy for early-stage 
lung cancer.
Definitively, the study of Yang and colleagues represents 
a step forward in this the definition of oncologic 
equivalency between VATS and open lobectomy procedure. 
It is worthy to note that in the present article, only about 
20% of patients were submitted to a VATS lobectomy, 
underlining the resiliency of the surgeons to abandon the 
open approaches (22). We hope that the results presented 
in this study could stimulate the production of evidence 
concerning oncological quality of VATS lobectomy 
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